Eppendorf Centrifuge 5920 R: the new benchmark in capacity and performance
Also offers a powerful state-of-the-art refrigeration system with advanced temperature management.
Eppendorf’s new refrigerated Centrifuge 5920 R combines extraordinary high capacity with enhanced temperature management in a very compact and ergonomic product design.
Centrifuge 5920 R can accommodate up to 4 x standard 1 Liter Nalgene bottles, as well as up to 108 x 15 mL conical tubes, and 52 x 50 mL conical tubes, enabling researchers to spin large volumes at any one time, in applications such as bioprocessing or cell culture. Additionally, the universal rotor bucket design means researchers can spin both plates and tubes in the same bucket without the need to purchase separate plate buckets.
Eppendorf’s Centrifuge 5920 R also offers a powerful state-of-the-art refrigeration system with advanced temperature management, meaning users can be confident that their temperature-sensitive samples are safe. Dynamic compressor control technology and a FastTemp pro function also allows precise and automated pre-cooling based on a pre-programmable time and date.
Easy to use, the Centrifuge 5920 R features a multi-lingual menu with backlit display with 5 program keys enabling rapid access to routine programs, as well as an adjustable ECO shut-off function to save energy and increase compressor life. “With laboratories under increasing pressure to increase efficiencies and throughput we understand the challenges that researchers face in their work,” said Peter Schreiner, Global Product Manager Centrifugation at Eppendorf. “The very large capacity and precise temperature management offered by the Centrifuge 5920 R means researchers can be assured that not only are their samples safe, but that they are saving time, money and energy with this system.”
Related News
-
News WuXi to sell CGT manufacturing unit to US-based Altaris LLC
At the tail end of 2024, Chinese-based CDMO WuXi AppTec announced the signing of their deal with private equity firm Altaris LLC, confirming the sale of WuXi Advanced Therapies, the cell and gene therapy manufacturing arm of WuXi AppTec. -
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan Wrap-Up Report: Conference Highlights
Discover the emerging and trending topics of the pharmaceutical industry with our CPHI Milan Conference Highlights, with exclusive insight from pharmaceutical leaders and experts! -
News BIOSECURE Act not included in key defense spending bill for 2025
On December 7, 2024, the Biden administration revealed the 2025 National Defense Authorization Act, an annual defense bill specifying the budget and expenditures of the US Department of Defense. The controversial BIOSECURE Act was notably missing from ... -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Trump 2.0: What does the US election result mean for the healthcare industry?
After Trump won the Presidential election in the US in early November, we take a look at some of the implications a new Trump administration could have on the health and pharmaceutical industry, and on US patients. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future. -
News Scaling the Industry: CPHI Scale-Up Market interview with YSK Laboratories
For the first time, CPHI Milan hosted the CPHI Start-Up Market, expanding support for emerging and small-sized enterprises in their transition to the next level of growth. In this interview, we spoke with Yuvansh Khokhani, Managing Director of YSK Labo...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance